These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24878952)

  • 1. Delayed diagnosis of Alport syndrome without hematuria.
    Yin-Yin C; You-Ming P; Yu-Mei L
    Iran J Kidney Dis; 2014 May; 8(3):250-1. PubMed ID: 24878952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare cause of nephrotic syndrome.
    Thomas RG; Senthilkumar RP; Velayudham B; Vasudevan C; Murugesan T
    Saudi J Kidney Dis Transpl; 2020; 31(3):676-680. PubMed ID: 32655053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From Alport syndrome to benign familial hematuria: clinical and genetic aspect].
    Maziers N; Dahan K; Pirson Y
    Nephrol Ther; 2005 May; 1(2):90-100. PubMed ID: 16895672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of Alport syndrome diagnosed by immunofluorescence using a newly defined monoclonal antibody].
    Ohtomo Y; Yabuta K; Shirato I; Tomino Y; Shirai T
    Nihon Jinzo Gakkai Shi; 1990 Jan; 32(1):105-10. PubMed ID: 2190029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of diagnosis and treatment of Alport syndrome].
    An XG; Zhang YQ; Ding J; Wang F; Xiao HJ; Yao Y
    Zhonghua Er Ke Za Zhi; 2016 Sep; 54(9):669-73. PubMed ID: 27596081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report and literature study on Alport syndrome featuring nephrotic syndrome as its primary manifestation.
    Deng Z; Zhou Q; Zhou TG
    Transpl Immunol; 2023 Dec; 81():101941. PubMed ID: 37866673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alport syndrome in 23-year-old woman].
    Finke D; Bilińska W; Kałuzyński A; Nowicki M
    Pol Merkur Lekarski; 2008; 24 Suppl 4():22-4. PubMed ID: 18924495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of proteinuria in a patient with X-linked Alport syndrome treated with cyclosporine.
    Sigmundsson TS; Palsson R; Hardarson S; Edvardsson V
    Scand J Urol Nephrol; 2006; 40(6):522-5. PubMed ID: 17130107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alport syndrome or progressive hereditary nephritis with hearing loss].
    Gubler MC; Heidet L; Antignac C
    Nephrol Ther; 2007 Jun; 3(3):113-20. PubMed ID: 17540313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
    Chen N; Pan X; Ren H; Dong D
    Chin Med J (Engl); 1998 Sep; 111(9):797-802. PubMed ID: 11155669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hematuria due to type IV collagen mutations: Alport syndrome and thin basement membrane nephropathy.
    Kashtan CE
    Curr Opin Pediatr; 2004 Apr; 16(2):177-81. PubMed ID: 15021198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
    Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
    Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and pathological study of 47 cases with Alport syndrome].
    He X; Liu GL; Xia ZK; Ren XG; Gao YF; Fan ZM; Fu YF; Fu J; Gao CL; Mao S; Chen R
    Zhonghua Er Ke Za Zhi; 2008 Dec; 46(12):914-8. PubMed ID: 19134254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rapidly progressive Alport syndrome in a young woman: case report].
    D'Elia L; Barreca A; Cencioni L; Ferraresi M; Marciello A; Rizzuto A; Perosa PM; Sandri L; Santirosi PV
    G Ital Nefrol; 2022 Feb; 39(1):. PubMed ID: 35191625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and pathological features of Alport syndrome in children].
    Zhu CH; Huang SM; Wu HM; Bao HY; Chen Y; Han Y; Zhao F; Zhang AH; Zhang WZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Mar; 12(3):188-91. PubMed ID: 20350427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tale of two nephropathies; co-occurring Alport syndrome and IgA nephropathy, a case report.
    Bhattacharyya A; Huang Y; Khan SH; Drachenberg CB; Malone LC
    BMC Nephrol; 2021 Oct; 22(1):358. PubMed ID: 34717572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematuria and risk for end-stage kidney disease.
    Vivante A; Calderon-Margalit R; Skorecki K
    Curr Opin Nephrol Hypertens; 2013 May; 22(3):325-30. PubMed ID: 23449218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nephropathy and deafness (Alport syndrome) without positive family history (author's transl)].
    Rüdiger HW; Gaertner U; Klapdor R; Neumann OG
    Med Klin; 1975 Feb; 70(8):337-40. PubMed ID: 1124046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alport syndrome misdiagnosed with IgA nephropathy from familial history: a case report and brief review.
    Rahimzadeh H; Ajlou S; Nili F; Razeghi E
    BMC Nephrol; 2023 Apr; 24(1):97. PubMed ID: 37059980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy complicated with Alport syndrome: a good obstetric outcome and failure to diagnose an infant born to a mother with Alport syndrome by umbilical cord immunofluorescence staining.
    Matsubara S; Ueda Y; Takahashi H; Nagai T; Kuwata T; Muto S; Yamaguchi T; Takizawa T; Suzuki M
    J Obstet Gynaecol Res; 2009 Dec; 35(6):1109-14. PubMed ID: 20144175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.